Literature DB >> 24955319

Virulence Factors of Staphylococcus aureus Isolates in an Iranian Referral Children's Hospital.

Farah Sabouni1, Shima Mahmoudi2, Abbas Bahador3, Babak Pourakbari1, Reihaneh Hosseinpour Sadeghi2, Mohammad Taghi Haghi Ashtiani4, Bahram Nikmanesh4, Setareh Mamishi5.   

Abstract

OBJECTIVES: The clinical importance of Staphylococcus aureus (S. aureus) is attributed to notable virulence factors, surface proteins, toxins, and enzymes as well as the rapid development of drug resistance. The aim of this study was to compare the occurrence of virulence factors produced by S. aureus strains isolated from children in an Iranian referral children's hospital.
METHODS: The presence of genes encoding for the enterotoxins A (sea), B (seb), C (sec), D (sed), TSST-1 (tsst), exfoliative toxin A (eta), and exfoliative toxin B (etb) were detected by Multiplex polymerase chain reaction (PCR) using specific primers. In addition, the standardized Kirby-Bauer disc-diffusion method was performed on Mueller-Hinton agar.
RESULTS: In total, 133 S. aureus isolates were obtained from different patients. Of these S. aureus isolates, 64 (48%) were methicillin-resistant S. aureus (MRSA), and all of these tested positive for the mecA gene. Regarding the classical enterotoxin genes, sea gene (40.6%) was the most prevalent followed by seb (19.6%), tsst (12.8%), eta (11.3%), etb (9%), sed (4.5%), and sec (3%). Among methicillin-susceptible S. aureus (MSSA) isolates, seb and tsst were the more prevalent toxins in comparison with MRSA isolates (p < 0.05), while the frequency of sea, sed, eta, and etb genes were higher among MRSA isolates (p > 0.05).
CONCLUSION: In our study enterotoxin A was produced by 40.6% of the isolates (48% from MRSA and 33% from MSSA isolates) which was higher than in previous reports. According to our results, strict hygiene and preventative measures during food processing are highly recommended.

Entities:  

Keywords:  Staphylococcus aureus; enterotoxins; exfoliative toxins; toxin of toxic shock syndrome-1

Year:  2014        PMID: 24955319      PMCID: PMC4064634          DOI: 10.1016/j.phrp.2014.03.002

Source DB:  PubMed          Journal:  Osong Public Health Res Perspect        ISSN: 2210-9099


Introduction

Staphylococcus aureus (S. aureus) is the most frequently isolated bacterium among both community-acquired and nosocomial infections [1]. S. aureus is the causal pathogen of a wide range of infectious diseases ranging from skin and soft tissue infections to toxin-mediated diseases such as pneumonia and bacteremia [2]. The clinical importance of S. aureus is attributed to notable virulence factors, surface proteins, toxins, and enzymes as well as the rapid development of drug resistance [3]. The most associated virulence factors with this microorganism are large numbers of toxins including hemolysins (α, β, γ, δ), leukocidins (Panton-Valentine leukocidin; PVL, LukE/D) [4,5], heat-stable staphylococcal enterotoxins (SEs), which cause the sporadic food-poisoning syndrome or food borne outbreaks, exfoliative toxins (ETA and ETB), and the toxin of toxic shock syndrome-1 (TSST-1) [6,7], which causes food poisoning, enterocolitis, scalded skin syndrome, and toxic shock [8]. The aim of this study was to compare the occurrence of virulence factors produced by S. aureus strains isolated from children in an Iranian referral children's hospital.

Material and methods

Sample collection

Clinical S. aureus samples were collected from hospitalized patients at an Iranian referral children's hospital in 2012.

Identification of S. aureus

Standard microbiological methods for the identification of microorganisms were applied. All specimens were inoculated onto mannitol salt agar and incubated at 37°C. The identification of S. aureus was performed by subsequent Gram staining, the catalase test, and the coagulase test with rabbit plasma [9].

Antimicrobial susceptibility test

The standardized Kirby-Bauer disc-diffusion method was performed on Mueller-Hinton agar using the following antibiotics: oxacillin (5 μg); vancomycin (30 μg); clindamycin (2 μg); rifampicin (30 μg); amikacin (30 μg); amoxicillin/clavulanic acid (30/15 μg); penicillin (10 μg); chloramphenicol (30 μg); trimethoprim sulfamethoxazole (1.25/23.75 μg); cefazolin (30 μg); and cephalothin (30 μg). Methicillin-susceptible S. aureus (MSSA) strains were differentiated from methicillin-resistant S. aureus (MRSA) using Mueller-Hinton agar containing 2 mg/mL oxacillin with 4% NaCl [10].

DNA extraction

DNA was extracted from S. aureus isolates using lysostaphin digestion [11]. The pellet of a 1-mL overnight culture was resuspended with 350 μL of lysis buffer (Tris-HCL 0.01 M, EDTA 0.01 M), to which 10 μL of lysostaphin were added. The sample was incubated at 37°C overnight. Equal volumes of phenol/chloroform/isoamylalcohol (25:24:1 by volume) were added, and nucleic acid was precipitated by ethanol using a standard protocol.

Polymerase chain reaction of the mecA

Confirmation of S. aureus and methicillin-resistance was achieved by polymerase chain reaction (PCR) targeting the mecA gene [10].

Multiplex PCR for the detection of toxin genes

The presence of genes encoding for enterotoxins A (sea), B (seb), C (sec), D (sed),TSST-1 (tsst), exfoliative toxin A (eta), and exfoliative toxin B (etb) was detected by Multiplex PCR using specific primers, as previously described [12]. Multiplex PCR was performed in a total volume of 50 μL containing 25 pmol of each primer, 50 ng of total DNA, 1.5 mM MgCl2, 200 μM dNTP mixture, 1× PCR reaction buffer, and 5 units of Taq DNA polymerase. The thermal cycling conditions included an initial denaturation step at 94°C for 5 minutes followed by 35 cycles of amplification comprising three steps: 2 minutes denaturation at 94°C; 1 minute annealing at 57°C; and 1 minute extension at 72°C, ending with a final extension at 72°C for 7 minutes.

Statistical analysis

A Microsoft Excel spreadsheet was used for data processing. For comparison tests between the positive isolates from each group, we used the Chi-square test and the Fischer's test for a lower number series. A p value < 0.05 was taken to be significant.

Results

In total, 133 S. aureus isolates were obtained from different patients. Fifty-seven patients (42.8%) were female (female to male ratio, 0.75), and the mean duration of a hospital stay was 13.25 ± 8.14 days. Forty-three patients (32.3%) were from the infection unit, with the remainder from the surgical ward (n = 27, 20.3%), NICU (n = 19, 14.3%), emergency ward (n = 10, 7.5%), ICU (n = 10, 7.5%), immunology ward (n = 10, 7.5%), gastroenterology ward (n = 7, 5.2%), and others (n = 7, 5.2%). Of the S. aureus isolates, 64 (48%) were MRSA and all of these tested positive for the mecA gene. The presence of toxin genes in the strains isolated from skin and soft tissue, blood, urinary, respiratory, and eye infections is shown in Table 1. The majority of toxin-producing S. aureus isolates were isolated from skin and soft tissue infections. There were no significant differences between toxin genes and the type of specimen.
Table 1

The frequency of toxin-producing Staphylococcus aureus based on different sites of infection

ToxinSkin & soft tissueEyeBloodUrineRespiratory
TSST7 (41.1%)2 (11.8%)7 (41.1%)01 (6%)
ETB8 (66.6%)2 (16.6%)1 (8.3%)01 (8.3%)
SEA28 (51.8%)4 (7.4%)15 (27.7%)1 (1.8%)6 (11.1%)
ETA11 (73.3%)2 (13.3%)01 (6.6%)1 (6.6%)
SEB12 (46.1%)3 (11.5%)6 (23%)3 (11.5%)2 (7.6%)
SEC3 (75%)01 (25%)00
SED2 (33.3%)1 (16.6%)2 (33.3%)1 (16.6%)0

ETA = exfoliative toxin A; ETB = exfoliative toxin B; SEA = staphylococcal enterotoxin A; SEB = staphylococcal enterotoxin B; SEC = staphylococcal enterotoxin C; SED = staphylococcal enterotoxin D; TSST = toxin of toxic shock syndrome-1.

Distribution of toxin-encoding genes

Regarding the classical enterotoxin genes, the sea gene (40.6%) was the most prevalent followed by seb (19.6%), tsst (12.8%), eta (11.3%), etb (9%), sed (4.5%), and sec (3%). Among MSSA isolates, seb and tsst were the more prevalent toxins in comparison with MRSA isolates (p < 0.05), while the frequency of the sea, sed, eta, and etb genes were higher among MRSA isolates (p > 0.05) (Table 2).
Table 2

The frequency of virulence genes of Staphylococcus aureus among MRSA and MSSA isolates

seasebsecsedetaetbtsstTotal
MRSA31 (48%)10 (15%)05 (8%)8 (12.5%)7 (11%)064
MSSA23 (33%)16 (23%)4 (6%)1 (1%)7 (10%)5 (7%)17 (23%)69
Total542646151217133

eta = exfoliative toxin A; etb = exfoliative toxin B; MRSA = methicillin-resistant Staphylococcus aureus; MSSA = methicillin-susceptible Staphylococcus aureus; sea = enterotoxin A; seb = enterotoxin B; sec = enterotoxin C; sed = enterotoxin D; tsst = enterotoxin TSST-1.

Antimicrobial susceptibility of toxin-producing S. aureus isolates

The sensitivity of the toxin-producing S. aureus isolates to the tested antibiotics is shown in Table 3. The sensitivity pattern showed that none of the toxin- producing S. aureus isolates were resistant to vancomycin, whereas all of them were resistant to penicillin. Interestingly, among these isolates, only SEC-producing isolates were susceptible to all of the tested antibiotics except penicillin, amikacin, and amoxicillin/clavulanic acid. Although the majority of the toxin-producing S. aureus isolates were susceptible to rifampicin, most of the SEA-producing isolates (90.8%) were resistant to this antibiotic. In addition, the most susceptible antibiotics among these isolates were chloramphenicol (76%) and clindamycin (76%). Although more than half of the toxin-producing S. aureus were MRSA, all TSST- and SEC-producing S. aureus isolates were susceptible to oxacillin.
Table 3

Antimicrobial susceptibility of toxin-producing Staphylococcus aureus isolates

ToxinOX
CF
CZ
SXT
C
P
AN
AMC
RIF
CC
V
N%N%N%N%N%N%N%N%N%N%N%
TSST171001694.11482.31694.11482.300423.5529.41694.11588.217100
ETB541.6866.6758.3866.61083.30018.318.3121001083.312100
SEA2342.62240.72240.71731.5417600712.959.259.2417654100
ETA746.6960960533.3128000426.6320151001173.315100
SEB1661.52061.52061.51557.72180.700830.7311.52596.1415.326100
SEC41004100410041004100000000410041004100
SED116.6350350350583.300233.300583.3466.66100

AMC = amoxicillin/clavulanic acid; AN = amikacin; C = chloramphenicol; CC = clindamycin; CF = cephalothin; CZ = cefazolin; ETA = exfoliative toxin A; ETB = exfoliative toxin B; OX = oxacillin; P = penicillin; RIF = rifampicin; SEA = staphylococcal enterotoxin A; SEB = staphylococcal enterotoxin B; SEC = staphylococcal enterotoxin C; SED = staphylococcal enterotoxin D; SXT = trimethoprim sulfamethoxazole; TSST = toxin of toxic shock syndrome-1; V = vancomycin.

Discussion

In our study SEA was produced by 40.6% of the isolates (48% from MRSA and 33% from MSSA isolates), which was higher than in previous reports [5,13,14]. In the Sina et al [5] study, among enterotoxin genes, the seb gene was the most prevalent (44%) followed by the sea gene (32%). However, the frequency of eta and etb was higher than in previous reports [5,13,14]. In the Kolawole et al [14] study in Nigeria, three (4.9%) of the isolates tested positive for the exfoliative toxin genes while no etb gene was detected. In another study conducted in China of 60 isolates, 30 isolates harbored enterotoxin genes, with sea being the most frequent toxin gene (33%), followed by sec (15%), sed (12%), and seb (5%) [15]. In the Sina et al [5] study, none of the strains contained the genes responsible for ETB or SED. In this study the TSST was found in 12.8% of the S. aureus isolates, all of which were MSSA. However, there are some studies that did not find the tsst gene in any or <1% of the strains of the isolates [5,15]. In addition, in our study, similar to the Machuca et al [16] report, the tsst gene was not detected in any of the MRSA isolates. In our study 48% of MRSA isolates harbored the sea gene, which was lower than reported in the Wang et al [15] study where up to 84.6% of MRSA isolates harbored the sea gene. However, other studies have reported a lower frequency of this gene among MRSA isolates [17,18]. Similar to the Wang et al [15] study, we did not detect the sec gene among MRSA isolates. However, there are some studies that have reported a higher frequency of this gene [13,15,17]. In this study, seb (23%) and tsst (23%) genes were more prevalent toxins among MSSA isolates. According to Araki et al [19], the incidence of the sec gene increased significantly in coagulase type II MRSA with the mecA gene, whereas we detected these genes only in MSSA isolates. Although in the Baba-Moussa et al [1] study, the majority of isolates which produced SEA, SEB, or SEC were MRSA, in our study 42.6% and 61.5% of SEA- and SEB-producing isolates were susceptible to methicillin, respectively. In view of the high resistance rates to penicillin, amikacin, and amoxicillin/clavulanic acid, empirical treatment of toxin-producing S. aureus infections with these antibiotics may not be effective. In addition, the high susceptibility of toxin-producing S. aureus to vancomycin and rifampicin indicates that these antibiotics are effective for the treatment of S. aureus infections at our hospital. It has been reported that antibiotic-resistant isolates might be transmitted to humans by the consumption of food products containing such resistant bacteria. Therefore, the extreme use of antibiotics as growth promoters in animal husbandry, especially for those which are frequently used for both humans and animals, should be avoided [6]. In addition, strict hygiene and preventative measures during food processing and also during the distribution and consumption of the final food product, in order to avoid the presence of S. aureus and SEs-producing strains in foods, are highly recommended.

Conflicts of interest

All contributing authors declare no conflicts of interest.
  17 in total

1.  Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance.

Authors:  M Mehrotra; G Wang; W M Johnson
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 2.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Clonal spreading of methicillin-resistant SCCmec Staphylococcus aureus with specific spa and dru types in central Taiwan.

Authors:  C-M Ho; M-W Ho; C-Y Lee; N Tien; J-J Lu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-26       Impact factor: 3.267

4.  Molecular analysis and frequency of Staphylococcus aureus virulence genes isolated from bloodstream infections in a teaching hospital in Tianjin, China.

Authors:  L X Wang; Z D Hu; Y M Hu; B Tian; Jing Li; F X Wang; H Yang; H R Xu; Y C Li; J Li
Journal:  Genet Mol Res       Date:  2013-03-11

5.  Genotypes, superantigen gene profiles, and presence of exfoliative toxin genes in clinical methicillin-susceptible Staphylococcus aureus isolates.

Authors:  Marijke J C A van Trijp; Damian C Melles; Susan V Snijders; Heiman F L Wertheim; Henri A Verbrugh; Alex van Belkum; Willem J van Wamel
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10-13       Impact factor: 2.803

Review 6.  Staphylococcus aureus: the toxic presence of a pathogen extraordinaire.

Authors:  E A Larkin; R J Carman; T Krakauer; B G Stiles
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  Genotyping of Staphylococcus aureus strains among healthcare workers and patients in the tertiary referral Children's Medical Hospital in Tehran, Iran.

Authors:  S Mamishi; S Mahmoudi; R H Sadeghi; Z Movahedi; R Hadipour; B Pourakbari
Journal:  Br J Biomed Sci       Date:  2012       Impact factor: 3.829

8.  Distribution of virulence genes in spa types of methicillin-resistant Staphylococcus aureus isolated from patients in intensive care units.

Authors:  Taeksoo Kim; Jongyoun Yi; Ki Ho Hong; Jeong-Su Park; Eui-Chong Kim
Journal:  Korean J Lab Med       Date:  2011-01

9.  Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections.

Authors:  Haziz Sina; Théodora A Ahoyo; Wardi Moussaoui; Daniel Keller; Honoré S Bankolé; Yves Barogui; Ymkje Stienstra; Simeon O Kotchoni; Gilles Prévost; Lamine Baba-Moussa
Journal:  BMC Microbiol       Date:  2013-08-08       Impact factor: 3.605

10.  Characterization of colonizing Staphylococcus aureus isolated from surgical wards' patients in a Nigerian university hospital.

Authors:  Deboye O Kolawole; Adeniran Adeyanju; Frieder Schaumburg; Akinyele L Akinyoola; Oladejo O Lawal; Yemisi B Amusa; Robin Köck; Karsten Becker
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more
  10 in total

1.  Survey of Staphylococcus aureus in a general pediatric population and focus on isolates with three clinically relevant toxin-encoding genes.

Authors:  Anne Filleron; Sarah Beauregard-Birba; Thibault Mura; Fabien Aujoulat; Anne Laure Michon; Michel Rodière; Tu Anh Tran; Eric Jeziorski; Hélène Marchandin
Journal:  World J Pediatr       Date:  2018-02-13       Impact factor: 2.764

2.  Investigation of Virulence Genes of the Predominant Bacteria Associated with Renal Stones and their Correlation with Postoperative Septic Complications.

Authors:  Asmaa E Ahmed; Hassan Abol-Enein; Amira Awadalla; Heba El Degla; Omar A El-Shehaby
Journal:  Infect Drug Resist       Date:  2022-07-09       Impact factor: 4.177

3.  New update on molecular diversity of clinical Staphylococcus aureus isolates in Iran: antimicrobial resistance, adhesion and virulence factors, biofilm formation and SCCmec typing.

Authors:  Mahtab Tabandeh; Hami Kaboosi; Mojtaba Taghizadeh Armaki; Abazar Pournajaf; Fatemeh Peyravii Ghadikolaii
Journal:  Mol Biol Rep       Date:  2022-01-21       Impact factor: 2.316

4.  High frequency of exfoliative toxin genes among Staphylococcus aureus isolated from clinical specimens in the north of Iran: Alarm for the health of individuals under risk.

Authors:  Mojtaba Mohseni; Fariba Rafiei; Ezzat Allah Ghaemi
Journal:  Iran J Microbiol       Date:  2018-06

5.  Antibiotic Resistance And Genotyping Of Gram-Positive Bacteria Causing Hospital-Acquired Infection In Patients Referring To Children's Medical Center.

Authors:  Setareh Mamishi; Maryam Mohammadian; Babak Pourakbari; Reihaneh Hosseinpour Sadeghi; Mohammad Taghi Haghi Ashtiani; Mohammad Reza Abdosalehi; Maryam Rahmani; Shima Mahmoudi
Journal:  Infect Drug Resist       Date:  2019-11-27       Impact factor: 4.003

6.  Distribution of virulence genes and SCCmec types among methicillin-resistant Staphylococcus aureus of clinical and environmental origin: a study from community of Assam, India.

Authors:  Deepshikha Bhowmik; Shiela Chetri; Bhaskar Jyoti Das; Debadatta Dhar Chanda; Amitabha Bhattacharjee
Journal:  BMC Res Notes       Date:  2021-02-10

7.  Phenotypic and genotypic virulence features of staphylococcal strains isolated from difficult-to-treat skin and soft tissue infections.

Authors:  Mădălina Preda; Mara Mădălina Mihai; Laura Ioana Popa; Lia-Mara Dițu; Alina Maria Holban; Loredana Sabina Cornelia Manolescu; Gabriela-Loredana Popa; Andrei-Alexandru Muntean; Irina Gheorghe; Carmen Mariana Chifiriuc; Mircea-Ioan Popa
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

8.  Genetic Diversity and Virulence Profile of Methicillin and Inducible Clindamycin-Resistant Staphylococcus aureus Isolates in Western Algeria.

Authors:  Zahoua Mentfakh Laceb; Seydina M Diene; Rym Lalaoui; Mabrouk Kihal; Fella Hamaidi Chergui; Jean-Marc Rolain; Linda Hadjadj
Journal:  Antibiotics (Basel)       Date:  2022-07-19

9.  Virulence genes distributed among Staphylococcus aureus causing wound infections and their correlation to antibiotic resistance.

Authors:  Asia Helmi Rasmi; Eman Farouk Ahmed; Abdou Mohammed Abdullah Darwish; Gamal Fadl Mahmoud Gad
Journal:  BMC Infect Dis       Date:  2022-07-28       Impact factor: 3.667

10.  Interactions between staphylococcal enterotoxins A and D and superantigen-like proteins 1 and 5 for predicting methicillin and multidrug resistance profiles among Staphylococcus aureus ocular isolates.

Authors:  Min Lu; Jean-Marie Parel; Darlene Miller
Journal:  PLoS One       Date:  2021-07-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.